Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
Lauren V CollenVanessa MitsialisDavid Y KimMairead BresnahanJessica YangMargaret TuthillAbigail CombsJared BarendsMichael FieldEnju LiuRichelle BearupIbeawuchi OkoroaforChristoph KleinAleixo M MuiseAthos BousvarosJodie D OuahedScott B SnapperPublished in: Inflammatory bowel diseases (2023)
Efficacy and safety of anti-TNFs in VEOIBD is comparable to what has previously been reported in older patients.